Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 2c, Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 26, 2024 4:05 PM ESTRevenue of $872.0 million, up 65% year-over-year in 2023
Net income of $1.2 million; Adjusted EBITDA profitability of $20.6 million in Q4 2023
Subscribers grew to 1.5 million, up 48% year-over-year in Q4 2023
Provides Q1 and full year 2024 guidance, with full year 2024 revenue in the range of $1.17 billion to $1.20 billion and Adjusted EBITDA in the range of $100 million to $120 million
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company) (NYSE: HIMS), the leading health and wellness platform, today announced... More
